[1]
K. Salimah, M. S. Hardianti, N. Anggorowati, and K. Taroeno-Hariadi, “Co-expression of BCL2 and C-MYC as a Potential Predictive Factor of Survival in Diffuse Large B Cell Lymphoma with Rituximab-Based Chemotherapy”, apjcb, vol. 11, no. 1, pp. 23-29, Jan. 2026.